Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort studyResearch in context
Summary: Background: Cardiovascular disease (CVD) and cancer are leading causes of death and people with cancer are at higher risk of developing CVD than the general population. Many cancer medicines have cardiotoxic effects but the size of the population exposed to these potentially cardiotoxic me...
Main Authors: | Benjamin Daniels, Maria Aslam, Marina T. van Leeuwen, Martin Brown, Lee Hunt, Howard Gurney, Monica Tang, Sallie-Anne Pearson, Claire M. Vajdic |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | The Lancet Regional Health. Western Pacific |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606523001906 |
Similar Items
-
Cancer therapy-induced cardiotoxicity: Review and algorithmic approach toward evaluation
by: K Purkayastha, et al.
Published: (2017-01-01) -
Comparison of Patients’ Phenotypes, Guideline-Directed Recommendations Compliance and Rates of Cardiotoxicity between Caribbean and United States Cardio-oncology Programs
by: Pamela Piña, et al.
Published: (2022-09-01) -
Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01) -
Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience
by: Michael G. Fradley, et al.
Published: (2017-07-01) -
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways
by: Ciro Mauro, et al.
Published: (2023-02-01)